Moderna | MRNA - Sales Revenues



Moderna reported $142M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Acadia Pharmaceuticals USD 264.6M 20.28M Jun/2025
Adcock Ingram Holdings ZAR 4.71B 188.47M Dec/2024
Agios Pharmaceuticals USD 12.45M 3.75M Jun/2025
Alnylam Pharmaceuticals USD 773.69M 179.5M Jun/2025
Amgen USD 9.18B 1.03B Jun/2025
Arrowhead Research USD 27.77M 514.94M Jun/2025
Biogen USD 2.6B 170M Jun/2025
BioMarin Pharmaceutical USD 825M 80M Jun/2025
Celltrion KRW 961.51B 119.6B Jun/2025
Cspc Pharmaceutical CNY 7.01B 691.61M Mar/2025
Dianthus Therapeutics USD 193K 1.13M Jun/2025
Divis Laboratories Ltd 24.1B 1.75B Jun/2025
Gilead Sciences USD 7.1B 430M Jun/2025
GlaxoSmithKline GBP 7.99B 470M Jun/2025
Incyte USD 1.06B 10M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
Kangmei Pharma CNY 1.27B 32.4M Jun/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Laboratorios Farma 159.7M 274.71M Jun/2025
Malin Corporation EUR 19.2M 2.6M Dec/2020
Moderna USD 142M 34M Jun/2025
Organigram Holdings CAD 70.79M 28.06M Jun/2025
Pharma Mar EUR 56.39M 17.49M Jun/2025
Qiagen NV USD 533.54M 108.24M Jun/2025
Regeneron Pharmaceuticals USD 3.68B 650M Jun/2025
Sarepta Therapeutics USD 611.09M 163.81M Jun/2025
Sartorius EUR 884.3M 1.3M Jun/2025
Sino Biopharmaceutical CNY 17.57B 1.7B Jun/2025
Tilray USD 308.01M 43.78M Jun/2025
Ultragenyx Pharmaceutical USD 166.5M 27.21M Jun/2025
United Therapeutics USD 798.6M 4.2M Jun/2025
Vertex Pharmaceuticals USD 2.96B 190M Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 2.24B 902.99M Jun/2025